Literature DB >> 179973

Effects of crp mutations on adenosine 3',5'-monophosphate metabolism in Salmonella typhimurium.

A W Rephaeli, M H Saier.   

Abstract

Wild-type Salmonella typhimurium could not grow with exogenous cyclic adenosine 3',5'-monophosphate (AMP) as the sole source of phosphate, but mutants capable of cyclic AMP utilization could be isolated provided the parental strain contained a functional cyclic AMP phosphodiesterase.All cyclic AMP-utilizing mutants had the growth and fermentation properties of cyclic AMP receptor protein (crp) mutants, and some lacked cyclic AMP binding activity in vitro. The genetic defect in each such mutant was due to a single point mutation, which was co-transducible with cysG. crp mutants isolated by alternative procedures also exhibited the capacity to utilize cyclic AMP. crp mutants synthesized cyclic AMP at increased rates and contained enhanced cellular cyclic AMP levels relative to the parental strains, regardless of whether or not cyclic AMP phosphodiesterase was active. Moreover, adenylate cyclase activity in vivo was less sensitive to regulation by glucose, possibly because the enzyme II complexes of the phosphotransferase system, responsible for glucose transport and phosphorylation, could not be induced to maximal levels. This possibility was strengthened by the observation that enzyme II activity (measured both in vitro by sugar phosphorylation and in vivo by sugar transport and chemotaxis) was inducible in the parental strain but not in crp mutants. The results suggest that the cyclic AMP receptor protein regulates cyclic AMP metabolism as well as catabolic enzyme synthesis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 179973      PMCID: PMC233041          DOI: 10.1128/jb.127.1.120-127.1976

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  26 in total

1.  ADENOSINE 3',5'-PHOSPHATE IN ESCHERICHIA COLI.

Authors:  R S MAKMAN; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1965-03       Impact factor: 5.157

2.  [Galactoside-permease of Escherichia coli].

Authors:  G BUTTIN; G N COHEN; J MONOD; H V RICKENBERG
Journal:  Ann Inst Pasteur (Paris)       Date:  1956-12

3.  Coordinate regulation of adenylate cyclase and carbohydrate permeases by the phosphoenolpyruvate:sugar phosphotransferase system in Salmonella typhimurium.

Authors:  M H Saier; B U Feucht
Journal:  J Biol Chem       Date:  1975-09-10       Impact factor: 5.157

4.  Regulation of intracellular adenosine cyclic 3':5'-monophosphate levels in Escherichia coli and Salmonella typhimurium. Evidence for energy-dependent excretion of the cyclic nucleotide.

Authors:  M H Saier; B U Feucht; M T McCaman
Journal:  J Biol Chem       Date:  1975-10-10       Impact factor: 5.157

5.  Cyclic 3', 5'-adenosine monophosphate phosphodiesterase mutants of Salmonella typhimurium.

Authors:  M D Alper; B N Ames
Journal:  J Bacteriol       Date:  1975-06       Impact factor: 3.490

6.  Measurement of cyclic 3',5'-denosine monophosphate by the activation of skeletal muscle protein kinase.

Authors:  W B Wastila; J T Stull; S E Mayer; D A Walsh
Journal:  J Biol Chem       Date:  1971-04-10       Impact factor: 5.157

7.  Pleiotropic deficiency of carbohydrate utilization in an adenyl cyclase deficient mutant of Escherichia coli.

Authors:  R L Perlman; I Pastan
Journal:  Biochem Biophys Res Commun       Date:  1969-09-24       Impact factor: 3.575

8.  Cyclic AMP receptor protein of E. coli: its role in the synthesis of inducible enzymes.

Authors:  M Emmer; B deCrombrugghe; I Pastan; R Perlman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

9.  A simple, sensitive method for the assay of adenyl cyclase.

Authors:  G Krishna; B Weiss; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1968-10       Impact factor: 4.030

10.  A protein binding assay for adenosine 3':5'-cyclic monophosphate.

Authors:  A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

View more
  17 in total

1.  Transport of antibiotics and metabolite analogs by systems under cyclic AMP control: positive selection of Salmonella typhimurium cya and crp mutants.

Authors:  M D Alper; B N Ames
Journal:  J Bacteriol       Date:  1978-01       Impact factor: 3.490

2.  Regulation of genes coding for enzyme constituents of the bacterial phosphotransferase system.

Authors:  A W Rephaeli; M H Saier
Journal:  J Bacteriol       Date:  1980-02       Impact factor: 3.490

3.  Mutations that affect transcription and cyclic AMP-CRP regulation of the adenylate cyclase gene (cya) of Salmonella typhimurium.

Authors:  J P Fandl; L K Thorner; S W Artz
Journal:  Genetics       Date:  1990-08       Impact factor: 4.562

4.  The cyclic 3',5'-adenosine monophosphate receptor protein and regulation of cyclic 3',5'-adenosine monophosphate synthesis in Escherichia coli.

Authors:  J L Botsford; M Drexler
Journal:  Mol Gen Genet       Date:  1978-09-20

Review 5.  Linkage map of Salmonella typhimurium, edition V.

Authors:  K E Sanderson; P E Hartman
Journal:  Microbiol Rev       Date:  1978-06

Review 6.  Cyclic nucleotides in procaryotes.

Authors:  J L Botsford
Journal:  Microbiol Rev       Date:  1981-12

7.  Isolation and characterization of an Escherichia coli mutant affected in the regulation of adenylate cyclase.

Authors:  C Guidi-Rontani; A Danchin; A Ullmann
Journal:  J Bacteriol       Date:  1981-12       Impact factor: 3.490

8.  Regulation of the synthesis of adenylate cyclase in Escherichia coli by the cAMP -- cAMP receptor protein complex.

Authors:  I H Majerfeld; D Miller; E Spitz; H V Rickenberg
Journal:  Mol Gen Genet       Date:  1981

9.  crpX mutants of Escherichia coli K12: specific regulatory effects of altered cyclic AMP receptor proteins.

Authors:  N Guiso; E Joseph; J Daniel
Journal:  Mol Gen Genet       Date:  1982

10.  Regulation of adenylate cyclase synthesis in Escherichia coli: studies with cya-lac operon and protein fusion strains.

Authors:  V A Bankaitis; P J Bassford
Journal:  J Bacteriol       Date:  1982-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.